#arthritis therapies

[pharmanucleus1]

Global Osteoarthritis Market: Trends, Treatment, and Projections 2030

Report Summary 

In 2023, the worldwide osteoarthritis market was valued at USD 7.40 billion and is predicted to increase at an 8.5% CAGR during the forecast period 2023-2030. Both the introduction of analgesic drugs and the development of imaging diagnostics based on radiographic characteristics are stimulating market growth. Increased expenditure on healthcare infrastructure and expanding investments in research and development (R&D) efforts to bring novel diagnostics and biomarkers are also driving the market. 

Osteoarthritis (OA) is a group of disorders that affect the joints of the knees, hips, fingers, foot, back, shoulders, and neck. It is distinguished by the gradual degeneration of the cartilage in these joints. Stiffness, edoema, discomfort, persistent pain, loss of flexibility, a grating sensation, bone spurs, and sleep interruptions are all common symptoms of OA. 

Click here for full report:

Medical examination, X-rays, arthroscopy, joint fluid analysis, lab testing, and magnetic resonance imaging (MRI) scans can all be used to diagnose it. Depending on the outcomes, different medications and surgical techniques are prescribed to treat the disease's signs and symptoms. There are presently alternative medicines, physical therapy, and supporting devices on the market to relieve pain and improve joint function. 

Sedentary lifestyles, poor eating habits, and increasing weight and blood sugar levels make people more susceptible to develop OA. This is one of the primary driving drivers for market development, combined with an ageing population that is more susceptible to such disorders. Furthermore, the ease of access to MRI scans is a key growth-promoting factor. 

The COVID-19 outbreak is predicted to have only a minimal influence on the osteoarthritis therapy industry. Corticosteroids are being used less often in many medicine types. Although there is no evidence that corticosteroid injections significantly increase the risk of infection, the immune system may be less active for a few weeks following surgery. 

Even though the risk is extremely minimal, it should be taken into account before starting with the procedure. It should be noted that the World Health Organisation cautioned against the use of systemic corticosteroids in one of its guidelines for treating severe acute respiratory infections caused by coronavirus. 

Industry Dynamics 

Growth Drivers:  

Increased government investment on cell-based research, as well as the increasing use of opioids, are driving market expansion. Topical, oral, and analgesic medications are commonly used to treat osteoarthritis pain. Even if alternatives such as orthopaedic braces are used as part of a noninvasive approach to pain therapy, the adoption of pain pills for the disease is substantial due to the ease of administration and the cost of pain medications. Oral analgesics such as acetaminophen, NSAIDs, intra-articular medicines, and nutraceuticals are all common pain relievers. 

Personalised OA medications have also been proposed, which would represent a considerable advance in the diagnosis, therapy, and monitoring of disease severity in osteoarthritis patients. Simple measurement, appropriate levels of sensitivity and specificity, and test procedures available to and interpretable by clinicians are critical qualities of indicators of therapeutic relevance for a personalised approach to OA therapy. 

The use of biomarkers to identify individuals who are most likely to respond to specific medical therapies may increase treatment response rates and reduce the risk of exposing patients to medicines that are either unlikely to be effective or may cause harmful side effects from their treatment. Using a mix of unique biomarkers and baseline clinical parameters such as age and gender might be beneficial. 

Report Segmentation 

The market is primarily segmented based on treatment type, disease type, distribution channel, route of administration, and region. 

Click here for full report:

Knee Osteoarthritis segment is expected to witness fastest growth 

Personalised OA medications have also been proposed, which would represent a considerable advance in the diagnosis, therapy, and monitoring of disease severity in osteoarthritis patients. Simple measurement, appropriate levels of sensitivity and specificity, and test procedures available to and interpretable by clinicians are critical qualities of indicators of therapeutic relevance for a personalised approach to OA therapy. 

Furthermore, increased FDA approvals for the treatment of Knee OA are driving sector growth throughout the projection period. For example, Novartis announced in September 2021 that LNA043 had been granted fast-track designation by the US Food and Drug Administration (FDA) for knee osteoarthritis rehabilitation. 

Drugs targeted to treat severe diseases and address unmet medical needs can be created more swiftly and evaluated more quickly. LNA043, a possibly first-in-class disease-modifying treatment for osteoarthritis, is being developed. As a result, growing approvals for the treatment of knee OA drive market development throughout the projection period. 

Click here for free sample request:

Viscosupplementation segment industry accounted for the highest market share in 2021 

The rising prevalence of knee osteoarthritis is the key driver of this market's expansion. By injecting synovial fluid into the afflicted joints, which increases lubrication, viscosupplementation greatly lowers osteoarthritis discomfort. Furthermore, the market for viscosupplementation agents is expected to grow considerably over the forecast period due to the discovery of novel viscosupplementation agents and government efforts to boost research in the healthcare sector. 

Hospital Pharmacies are expected to hold the significant revenue share 

Hospital pharmacies retained the largest share of this market due to the large number of patients seeking treatment for osteoarthritis in hospitals and the vast assortment of osteoarthritis drugs available in these pharmacies. Another important advantage is the ease with which hospital pharmacy purchases may be reimbursed. 

The demand in North America is expected to witness significant growth 

A rise in the frequency of chronic diseases, an increase in the number of elderly people, and changes in people's lifestyles all contribute to the anticipation of market expansion in North America. As a result, the region is incorporating an increasing number of treatments and drugs. When compared to Canada and Mexico, the United States will command a substantial share of the North American market for osteoarthritis therapies. 

According to the CDC, osteoarthritis (OA), the most common kind of arthritis, is a severe chronic illness that affects 32.5 million individuals in the United States. OA is associated with ageing and is more common in those with other chronic conditions such as obesity, diabetes, and heart disease. However, 18.7 million people with OA, or more than half of them, are of working age (18 to 64 years). 

Furthermore, the availability of better treatment alternatives, government reimbursement guidelines, increased research and development activities in the creation of novel medicines, and the introduction of new therapies in the North American region are all expected to support market expansion in the region. 

Europe controlled the market for osteoarthritis therapies. The increased incidence of osteoarthritis, the ageing population, rising obesity rates in several European countries, and the growing number of sports- and accident-related injuries all contribute to this sector's large market share. 

[genzforbettergenerations]

Since I’ve never seen any kind of positivity post for this:

Shout out to people who get IV infusions weekly, biweekly, monthly, multiple times a year.

Shout out to people whose hands/arms/elbows/feet/legs are covered in scars and scar tissue. Shout out to people whose scar tissue hurts or locks up joints. Shout out to people who are covered in bruises after getting an IV.

Shout out to people whose veins roll or disappear, people who need multiple sticks or digging to get a vein. Shout out to people whose veins blow when getting IVs or during infusions. Shout out to people who feel like their veins have no more to give.

Shout out to people who cry or need someone to hold onto when getting an IV. Shout out to people who have anxiety or panic attacks when getting or thinking about IVs/infusions.

Shout out to people who will continue to need IV infusions into the foreseeable future. Shout out to people who will continue to need IV infusions for the rest of their lives. Shout out to the people who leave their IV in for several days, and thus need to cover it and continue with school, jobs, chores, etc, and sleep with it in.

Shout out to the kids and teens who need IV infusions.

Shout out to people who feel self-conscious about their IV scars. Shout out to people who worry about someone noticing them and treating them differently (though no one should be shamed for their scars, no matter how they got them).

Shout out to people who are traumatized from IVs/infusions. Shout out to people who have terrible memories associated with IVs/infusions.

Shout out to people who go to the hospital for infusions. Shout out to people who get infusions at home. Shout out to people who lose hours of their days while getting infusions.

You are no less worthy of love and positivity because you need IV infusions.

--

Anyone can reblog (and please do!), but only people who need (or have needed) regular/intermittent IV infusions should add on.

[flamingo--ing]

ADAPTIVE WATERSKIING

[annasellheim]

Next part

[coachbeards]

im not a roy expert so idk if he would or not but…picturing roy getting a dog

[brunchbitch]

So I’ve had three PT sessions so far as sort of a tune up for my back issues. I’ve been surprised at how much weakness I have in certain muscles (especially around my hips). It feels like each time I go in, she has to make the exercises even more basic to try to limit pain. And it’s so frustrating - with my job, it’s come into even starker focus how young I am to be having these issues. I spoke to my PT about that and she was like “yes you are young, but you also have a lot going on in your back”.

Today she gave me this thick belt thing that I could wear daily to stabilize my sacroiliac joints (basically sits low on my hips). I was hoping it wasn’t what I needed bc it reminds me of back braces (though obviously much much smaller and less noticeable) but as soon as I put it on, the lower back pain on my right side disappeared. I won’t wear it to bed (whereas the back braces I would) so that’s nice, and it’s just a temporary thing while we’re focusing on strengthening the muscles around it, AND it’s amazing that something so small could help my lower back pain, but it’s still hard to come to terms with.

When I was 12 and approaching this massive life changing and life saving back surgery, the surgeon told me I would be able to do everything after the surgery that I did before, with the exception of something like gymnastics or very high impact sports like football. But I started running at age 16/17 and got a stress fracture in three vertebrae right below where the fusion ended, and since then it feels like I haven’t been without some sort of pain throughout my back/neck. I was reading back through some of my medical records and I didn’t realize that even after the fusion, my curves are still 24 and 35 degrees I think? Which would be significant curves for someone who hasn’t had surgery. My PT has told me definitively that I will need surgery to extend the fusion in my lumber/sacral joints; it’s just a matter of when. I hope to put it off for as long as possible, but it feels so defeating and scary to think of how much more my mobility will be affected. And my ED brain is definitely using this as a way to argue that I absolutely need to lose weight to support my skeletal/muscular system.

[golden-girl-daisy]

Poor Honey has arthritis in both of her shoulders even though she’s only 3. The vet suggested she try PRP therapy

[dwarf-vader-of-middle-earth]

Nothing is ok. Everything's fucked. I hate being alive.

[fleshadept]

really not sure what my knee wants from me when it aches and spasms when i don't move and then does when i move "too much". but what is too much. i literally just walked to and from lunch

[bluepunkmon]

Last Trigun post for now, headcanon that due to the accelerated growth and constant damage and healing he goes through, Wolfwood's joints are absolutely fucked

[pharmanucleus1]

Global Osteoarthritis Market, Forecast to 2030

In 2023, the worldwide osteoarthritis market was valued at USD 7.40 billion and is predicted to increase at an 8.5% CAGR during the forecast period 2023-2030. Both the introduction of analgesic drugs and the development of imaging diagnostics based on radiographic characteristics are stimulating market growth. Increased expenditure on healthcare infrastructure and expanding investments in research and development (R&D) efforts to bring novel diagnostics and biomarkers are also driving the market. 

Osteoarthritis (OA) is a group of disorders that affect the joints of the knees, hips, fingers, foot, back, shoulders, and neck. It is distinguished by the gradual degeneration of the cartilage in these joints. Stiffness, edoema, discomfort, persistent pain, loss of flexibility, a grating sensation, bone spurs, and sleep interruptions are all common symptoms of OA. 

Click here for view full report:

Medical examination, X-rays, arthroscopy, joint fluid analysis, lab testing, and magnetic resonance imaging (MRI) scans can all be used to diagnose it. Depending on the outcomes, different medications and surgical techniques are prescribed to treat the disease's signs and symptoms. There are presently alternative medicines, physical therapy, and supporting devices on the market to relieve pain and improve joint function. 

Sedentary lifestyles, poor eating habits, and increasing weight and blood sugar levels make people more susceptible to develop OA. This is one of the primary driving drivers for market development, combined with an ageing population that is more susceptible to such disorders. Furthermore, the ease of access to MRI scans is a key growth-promoting factor. 

Click here for Request free sample:

The COVID-19 outbreak is predicted to have only a minimal influence on the osteoarthritis therapy industry. Corticosteroids are being used less often in many medicine types. Although there is no evidence that corticosteroid injections significantly increase the risk of infection, the immune system may be less active for a few weeks following surgery. 

Even though the risk is extremely minimal, it should be taken into account before starting with the procedure. It should be noted that the World Health Organisation cautioned against the use of systemic corticosteroids in one of its guidelines for treating severe acute respiratory infections caused by coronavirus. 

Industry Dynamics 

Growth Drivers:  

Increased government investment on cell-based research, as well as the increasing use of opioids, are driving market expansion. Topical, oral, and analgesic medications are commonly used to treat osteoarthritis pain. Even if alternatives such as orthopaedic braces are used as part of a noninvasive approach to pain therapy, the adoption of pain pills for the disease is substantial due to the ease of administration and the cost of pain medications. Oral analgesics such as acetaminophen, NSAIDs, intra-articular medicines, and nutraceuticals are all common pain relievers. 

Personalised OA medications have also been proposed, which would represent a considerable advance in the diagnosis, therapy, and monitoring of disease severity in osteoarthritis patients. Simple measurement, appropriate levels of sensitivity and specificity, and test procedures available to and interpretable by clinicians are critical qualities of indicators of therapeutic relevance for a personalised approach to OA therapy. 

The use of biomarkers to identify individuals who are most likely to respond to specific medical therapies may increase treatment response rates and reduce the risk of exposing patients to medicines that are either unlikely to be effective or may cause harmful side effects from their treatment. Using a mix of unique biomarkers and baseline clinical parameters such as age and gender might be beneficial. 

Report Segmentation 

The market is primarily segmented based on treatment type, disease type, distribution channel, route of administration, and region. 

Knee Osteoarthritis segment is expected to witness fastest growth 

Personalised OA medications have also been proposed, which would represent a considerable advance in the diagnosis, therapy, and monitoring of disease severity in osteoarthritis patients. Simple measurement, appropriate levels of sensitivity and specificity, and test procedures available to and interpretable by clinicians are critical qualities of indicators of therapeutic relevance for a personalised approach to OA therapy. 

Click here for view full report:

Furthermore, increased FDA approvals for the treatment of Knee OA are driving sector growth throughout the projection period. For example, Novartis announced in September 2021 that LNA043 had been granted fast-track designation by the US Food and Drug Administration (FDA) for knee osteoarthritis rehabilitation. 

Drugs targeted to treat severe diseases and address unmet medical needs can be created more swiftly and evaluated more quickly. LNA043, a possibly first-in-class disease-modifying treatment for osteoarthritis, is being developed. As a result, growing approvals for the treatment of knee OA drive market development throughout the projection period. 

[blueheartedwolf]

I wish I could find a doctor that wants to find out what’s actually wrong with me instead of recommending prescriptions to address the symptoms. I’m so tired of being recommended ibuprofen for debilitating pain. Tired of relaying my medical history to a new doctor and getting the same furrowed brow and shrugging shoulders I get every time. Tired of having so-called medical professionals ask why I need a cane if I’m able to walk down their clinic hallway without it. When will someone fucking help me?

[after-witch]

Are you adjusting well after the move?

honestly--

nope, nope, nope, not at all. I'm not doing well in a serious way.

I feel very mentally displaced because I can't unpack anything extra due to my most recent back injury, so my apartment is still just Boxes and A Handful of Essential Things right now. I had to reschedule an appointment for my back issue, so hopefully I can get in soon.

I'm finding it difficult to finish things (commissions, work, anything personal) because my back issue after pulling it on Day 3 of Living Here makes sitting at a computer flare up my back pain.

But because of my feet issues, I can't stand for long periods either. I'm just constantly battling pain, inability to do normal things, while also still trying to work & take care of myself & eat food that is vaguely healthy for me.

I just feel like I'm stuck in metaphorical syrup right now, and I'm struggling to get to a flat surface where I can get balanced again. If that makes sense.

Sorry for the rant 'non, I appreciate you asking, i just wish I was doing better.

good thing:

I really do like my apartment & the area. It's a small town that I used to visit all the time when I'd get dropped off for doctor's appointments, and my apartment is within walking distance to a downtown area with quite a bit to do. (library! movies! an old fashioned arcade! parks & biking trails I can use once I get my bike fixed up!) My neighbors are totally fine and the set-up of where my apartment is in the building gives me more privacy than I thought I'd have.

edit: also I told myself I'd try to unpack one box before I go to sleep because it's on top of a table and I can reach it and BAM, finally found my desk microphone that I use when I can't type because of elbow flare-ups, but now I can use it while standing or walking around to write!! fucking yes. thank you, random box.

[maxisanangrywell]

in case anyone is wondering what its like to be chronically ill, i stressed myself out so bad this week my body has defaulted to "stress = vomit" mode. which is making my stomach and various joints hurt and i just pulled a muscle for vomiting too hard.

love life, life dont love me

[canipetthatdeaddove]

Oh noooo not physical therapy twice a week for six weeks where at the end of every sesh I get hit towels and the wonderful amazing muscle stimulator nooo not thaaaat.

I'm aging but I still got lots of good movement left in me that it is important to maintain, especially through substance abuse recovery and weight loss. I'm glad my state issues insurance covers this for me with no out of pocket expense. It's a bit of a luxury.

[gramarobin]

I'm considering trying edible or topical medicinal cbd with thc for arthritis pain. I've read 2:1 ratio is good...Any tips welcome as I have no idea what would help.